“Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway”. Nigerian Journal of Physiological Sciences, c. 40, sy 2, Aralık 2025, ss. 251-62, https://doi.org/10.54548/.